10X Genomics Inc (TXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -182,627 | -255,099 | -166,000 | -58,223 | -542,731 |
| Depreciation Amortization | 43,708 | 43,619 | 33,006 | 28,254 | 19,021 |
| Accounts receivable | 26,951 | -10,613 | -18,948 | -34,041 | -17,847 |
| Accounts payable and accrued liabilities | -3,354 | -6,017 | 5,858 | 11,084 | -7,770 |
| Other Working Capital | 2,338 | 18,021 | -40,342 | -88,490 | -50,381 |
| Other Operating Activity | 119,648 | 194,892 | 152,820 | 120,043 | 381,810 |
| Operating Cash Flow | $6,664 | $-15,197 | $-33,606 | $-21,373 | $-217,898 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -19,238 | 183,016 | -215,226 | N/A | N/A |
| PPE Investments | -12,393 | -48,601 | -131,661 | -101,278 | -36,666 |
| Net Acquisitions | N/A | N/A | -4,000 | -5,451 | N/A |
| Purchase Sale Intangibles | -1,000 | -923 | N/A | N/A | -1,728 |
| Other Investing Activity | -1,000 | -923 | 0 | 0 | -1,728 |
| Investing Cash Flow | $-32,631 | $133,492 | $-350,887 | $-106,729 | $-38,394 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -5,814 | -5,409 | -5,028 | -37,104 |
| Common Stock Issued | 10,914 | 19,483 | 21,226 | 40,325 | 506,010 |
| Financing Cash Flow | $10,914 | $13,669 | $15,817 | $35,297 | $468,906 |
| Exchange Rate Effect | -164 | -33 | -44 | 234 | -463 |
| Beginning Cash Position | 359,284 | 227,353 | 596,073 | 688,644 | 476,493 |
| End Cash Position | 344,067 | 359,284 | 227,353 | 596,073 | 688,644 |
| Net Cash Flow | $-15,217 | $131,931 | $-368,720 | $-92,571 | $212,151 |
| Free Cash Flow | |||||
| Operating Cash Flow | 6,664 | -15,197 | -33,606 | -21,373 | -217,898 |
| Capital Expenditure | -12,393 | -48,601 | -131,661 | -101,278 | -36,666 |
| Free Cash Flow | -5,729 | -63,798 | -165,267 | -122,651 | -254,564 |